Juliana Swink v. Southern Health Partners Incorporated

CourtCourt of Appeals for the Fourth Circuit
DecidedNovember 20, 2025
Docket21-2183
StatusPublished

This text of Juliana Swink v. Southern Health Partners Incorporated (Juliana Swink v. Southern Health Partners Incorporated) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Juliana Swink v. Southern Health Partners Incorporated, (4th Cir. 2025).

Opinion

USCA4 Appeal: 21-2183 Doc: 93 Filed: 11/20/2025 Pg: 1 of 60

PUBLISHED

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 21-2183

JUILIANA SWINK, Administratrix of the Estate of David Ray Gunter,

Plaintiff - Appellant,

v.

SOUTHERN HEALTH PARTNERS INC.; JASON JUNKINS, Medical Director; DAVIE COUNTY; ANDY STOKES; CAMERON SLOAN; STOKES COUNTY; MIKE MARSHALL; ERIC CONE; SANDRA HUNT; FRAN JACKSON; WESTERN SURETY COMPANY; MANUEL MALDONADO; DOE DEFENDANTS; OHIO CASUALTY INSURANCE COMPANY,

Defendants – Appellees,

and

DR. MANDY K. COHEN, Secretary of DHHS; DEPARTMENT OF HEALTH AND HUMAN SERVICES,

Defendants.

Appeal from the United States District Court for the Middle District of North Carolina, at Greensboro. William L. Osteen, Jr., District Judge. (1:16-cv-00262-WO-JLW)

Argued: October 30, 2024 Decided: November 20, 2025

Before GREGORY, RICHARDSON, and BENJAMIN, Circuit Judges.

Affirmed in part, reversed in part, and remanded by published opinion. Judge Gregory wrote the opinion, in which Judge Benjamin joined. Judge Richardson wrote a separate opinion, concurring the judgment in part and dissenting in part. USCA4 Appeal: 21-2183 Doc: 93 Filed: 11/20/2025 Pg: 2 of 60

ARGUED: David W. McDonald, MCDONALD WRIGHT LLP, Greensboro, North Carolina, for Appellant. James G. Long, III, MAYNARD NEXSEN PC, Columbia, South Carolina; Bradley O. Wood, WOMBLE BOND DICKINSON (US) LLP, Winston-Salem, North Carolina, for Appellees. ON BRIEF: Brittany N. Clark, NEXSEN PRUET, LLC, Columbia, South Carolina, for Appellees Southern Health Partners, Inc.; Jason Junkins; Sandra Hunt; Fran Jackson; and Manuel Maldonado.

2 USCA4 Appeal: 21-2183 Doc: 93 Filed: 11/20/2025 Pg: 3 of 60

GREGORY, Circuit Judge:

I.

Appellant David Ray Gunter was diagnosed with a heart condition shortly after

birth. J.A. 669, Deposition of David Ray Gunter (“Gunter Dep.”) 35:14–23. At fifteen

years old, to address his heart condition, Gunter underwent open-heart surgery to replace

his aortic valve with a mechanical heart valve (“MHV”). J.A. 670, Gunter Dep. 36:7–11.

At this time, Gunter was also prescribed Coumadin, an anticoagulant or blood thinner,

which reduces the formation of blood clots. Id. Gunter “faithfully and regularly took his

Coumadin dosage at a set hour every day” and such regimen “was effective and [Gunter]

did not suffer serious complications from his heart condition provided that he faithfully

observed his physicians’ instructions.” J.A. 245.

Individuals with MHVs have a higher risk of blood clots than those without MHVs.

J.A. 2147. To ensure such patients are receiving the appropriate amount of Coumadin,

providers monitor the patient’s International Normalized Ratio (“INR”) range, which

indicates, amongst other things, the blood’s thickness and clotting factors. Id. It is

important for individuals with MHVs to maintain levels of anticoagulant within a

therapeutic range and that the levels of anticoagulant do not fall above or below the

therapeutic range. J.A. 245. An appropriate or “therapeutic” INR level for an individual

with an MHV is between 2.5 and 3.5. See J.A. 695, Deposition of Virginia Glover Yoder

(“Yoder Dep.”) 201:14–15; J.A. 1925 ¶ 5. An individual with an MHV that has an INR

level below the “therapeutic” range is at risk for clot formation, while an individual with

3 USCA4 Appeal: 21-2183 Doc: 93 Filed: 11/20/2025 Pg: 4 of 60

an MHV that has an INR level above the “therapeutic” range is at risk for excessive

bleeding. See J.A. 682, Yoder Dep. 78:4–2. Gunter typically took Coumadin once per day

in the evening. J.A. 674, Gunter Dep. 80:9–10. Over the years, Gunter’s daily dosage has

fluctuated between 5mg and 7mg per day due to various factors, including financial access

to medication, diet, and metabolism needs. J.A. 673, Gunter Dep. 74:19; see also J.A. 533.

In early 2012, Gunter was treated by Dr. Virginia Yoder at a Coumadin clinic in North

Carolina. J.A. 1977. Due to financial difficulties, Gunter had trouble securing reliable

transportation to his appointments, and subsequently, was discharged from the clinic on May

31, 2012 for failure to attend. J.A. 695, Yoder Dep. 201:4–7; see also J.A. 1977. Between

May 2012 and November 2012, Gunter asserts he provided lawn care services for a doctor,

who, in exchange for this labor, provided Coumadin and INR testing. See J.A. 1977, 2199.

On November 6, 2012, Gunter was arrested in Forsyth County pursuant to a bench

warrant and was temporarily placed at the Forsyth County local confinement facility. J.A.

245; see also J.A. 672, Gunter Dep. 54:13–20. When Gunter arrived at the Forsyth County

local confinement facility, “he completed a medical intake form, disclosing that he has a heart

condition and alerting that he takes Warfarin1 daily together with other medications and other

medical information.” J.A. 245.

On the morning of November 7, 2012, Gunter was transferred to Davie County

Detention Center (“DCDC”). J.A. 246. Upon his arrival, Gunter was screened by appellee

1 The generic brand of Coumadin is referred to as “Warfarin,” and both brands are used interchangeably by the parties’ witnesses and district court. See J.A. 1218, Gunter Dep. 36:12–15. For consistency purposes, this opinion will only refer to Gunter’s prescribed medication as Coumadin.

4 USCA4 Appeal: 21-2183 Doc: 93 Filed: 11/20/2025 Pg: 5 of 60

Fran Jackson, a nurse and the Davie County Medical Team Administrator for appellee

Southern Health Partners, Inc. (“SHP”), the contracted medical care provider for DCDC. J.A.

94, 246, 566–77, 675, Gunter Dep. 81:7–14. Gunter advised Jackson that he had an MHV and

took Coumadin, which she noted in his medical record. J.A. 94, 532–33. Jackson further

noted that Gunter advised he would have his medications brought to DCDC if he was not

released and advised Jackson to call his doctors if he was not released. J.A. 533. Gunter states

Jackson was not “very nice” and “when she listened to [Gunter’s] heart clicking” stated “[j]ust

because your heart clicks doesn’t mean you have a mechanical heart valve.” J.A. 1228, Gunter

Dep. 88:17–25.

On the morning of November 8, 2012, Jackson contacted Gunter’s primary care

physician and pharmacist about his condition. J.A. 533. According to Jackson’s notes in the

medical records, the clinic where Gunter stated his primary physician worked had last seen

Gunter in June 2012 for a sick visit, but otherwise had not managed his INR levels since 2010.

Id. Jackson’s notes in the medical records further indicated the pharmacist informed Jackson

that Gunter had last filled a prescription for 1mg of Coumadin on October 19, 2012, and did

not have any prescriptions remaining. Id. Jackson also received a faxed medical record from

a clinic, which indicated Gunter reported taking 7mg of Coumadin by mouth daily.

That same day, Jackson consulted with appellee Manuel Maldonado, a licensed

Physician’s Assistant and independent contractor for SHP who oversaw medical care at DCDC

and Stokes County Detention Center (“SCDC”). J.A. 375; J.A. 648, Deposition of Manuel

Maldonado (“Maldonado Dep.”) 30:6–24. Maldonado ordered a prescription for 5mg of

Coumadin and arranged for Gunter to have an INR test completed on November 13, 2012. J.A.

5 USCA4 Appeal: 21-2183 Doc: 93 Filed: 11/20/2025 Pg: 6 of 60

1303–04, Maldonado Dep. 83:20–25, 84:1–5. Additionally, that same day, Gunter’s family

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Erie Railroad v. Tompkins
304 U.S. 64 (Supreme Court, 1938)
Thorpe v. Housing Authority of Durham
393 U.S. 268 (Supreme Court, 1969)
Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
West v. Atkins
487 U.S. 42 (Supreme Court, 1988)
Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
United States v. Johnson
617 F.3d 286 (Fourth Circuit, 2010)
Owens v. Bourns, Inc.
766 F.2d 145 (Fourth Circuit, 1985)
Rohrbough v. Wyeth Laboratories, Inc.
916 F.2d 970 (Fourth Circuit, 1990)
Rasheed Olds v. United States
473 F. App'x 183 (Fourth Circuit, 2012)
King v. Kramer
680 F.3d 1013 (Seventh Circuit, 2012)
Henderson v. United States
133 S. Ct. 1121 (Supreme Court, 2013)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Weatherford v. Glassman
500 S.E.2d 466 (Court of Appeals of North Carolina, 1998)
Medlin v. Bass
398 S.E.2d 460 (Supreme Court of North Carolina, 1990)
State v. Wilson
643 S.E.2d 620 (Court of Appeals of North Carolina, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Juliana Swink v. Southern Health Partners Incorporated, Counsel Stack Legal Research, https://law.counselstack.com/opinion/juliana-swink-v-southern-health-partners-incorporated-ca4-2025.